Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NanoString Technologies has announced the signing of the second early-access agreement for the nCounter analysis system for digital gene expression with the Genome Sequencing Center at the Washington University School of Medicine.
Subscribe to our email newsletter
The nCounter analysis system at Washington University will be utilized first for a large-scale diabetes study to validate the expression of over 50 genes across 15 tissues in over 900 samples.
The company said that the nCounter analysis system uses a novel digital technology that enables direct multiplexed measurement of gene expression and offers high levels of sensitivity and precision, including detection of fractional fold change differences, a feature unique to this platform.